Document is current

Any future updates will be listed below

Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1

Crossref DOI link: https://doi.org/10.1038/leu.2015.42

Published Online: 2015-02-13

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark